Clark AS, Hong F, Finn RS, DeMichele AM, et al. Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B. Clin Cancer Res 2023;29:1477-1483.
PMID: 36853016